Categories: Research

UCSF helps launch Chinese course on drug development

The UCSF School of Pharmacy was a key collaborator in the early January 2009 launch of a course in China that ultimately hopes to contribute to the improved quality and broader acceptance of Chinese pharmaceuticals and pharmaceutical exports.

Pharmacogenomics research spans school agenda

Pharmacogenomics research at the UCSF School of Pharmacy extends from a better understanding of information derived from the Human Genome Project to research on specific genetic differences in humans and how they might affect an individual's response to a medication.

Kroetz elected fellow of American Association of Pharmaceutical Scientists

Deanna Kroetz, PhD, UCSF School of Pharmacy faculty member, has been elected as a fellow of the American Association of Pharmaceutical Scientists (AAPS).

Bero and team reveal incomplete reporting of clinical drug trial data

Research by UCSF School of Pharmacy faculty member Lisa Bero, PhD, and UCSF colleagues Kristen Rising, MD, and Peter Bacchetti,

Drug development course teaches professionals to see bigger picture

The path from scientific insight to a new drug used to treat patients is a long, expensive, inefficient, hazard-strewn obstacle course requiring many steps before the drug arrives at the pharmacy. Unfortunately, the specialists working at each of these steps do not necessarily have a clear vision...

Wells notes need for academia in drug discovery research and advocacy

James Wells, PhD, chair, department of pharmaceutical chemistry in the UCSF School of Pharmacy, shares his thoughts on the need for increased public awareness about the ultimate value of science to health and the opportunities now presenting themselves to university scientists

Advocates needed for basic science research

Scientists need to speak out now—as individuals and through advocacy groups—to educate the public about the importance of basic science research and to rally support for more funding, according to an October 3, 2008 editorial in Science.

Phillips awarded $5 Million NCI grant to study personalized medicine

The wider world use of medical tests and treatments based on individual genetic differences is the focus of a new, US$5 million research program funded by the National Cancer Institute (NCI) and led by UCSF School of Pharmacy health economist Kathryn Phillips,

UCSF graduate student among first-place winners of STEP White Paper Competition 2008

UCSF biophysics PhD student Gabriel Rocklin and Jacob Heller, Stanford University law student, were first-place winners, with a second team, of the Science, Technology and Engineering Policy (ST

Pages